ATE314465T1 - Verfahren zum screening von hochaktiven proteasen und hemmstoffen - Google Patents

Verfahren zum screening von hochaktiven proteasen und hemmstoffen

Info

Publication number
ATE314465T1
ATE314465T1 AT01960178T AT01960178T ATE314465T1 AT E314465 T1 ATE314465 T1 AT E314465T1 AT 01960178 T AT01960178 T AT 01960178T AT 01960178 T AT01960178 T AT 01960178T AT E314465 T1 ATE314465 T1 AT E314465T1
Authority
AT
Austria
Prior art keywords
protease
gene
inhibitors
highly active
active proteases
Prior art date
Application number
AT01960178T
Other languages
English (en)
Inventor
Poul Erik Pedersen
Mads Noerregaard-Madsen
Original Assignee
Novozymes As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novozymes As filed Critical Novozymes As
Application granted granted Critical
Publication of ATE314465T1 publication Critical patent/ATE314465T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6402—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals
    • C12N9/6405—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from non-mammals not being snakes
    • C12N9/6408—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
AT01960178T 2000-08-29 2001-07-17 Verfahren zum screening von hochaktiven proteasen und hemmstoffen ATE314465T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200001273 2000-08-29
PCT/DK2001/000503 WO2002018588A1 (en) 2000-08-29 2001-07-17 Method for screening highly active proteases and inhibitors

Publications (1)

Publication Number Publication Date
ATE314465T1 true ATE314465T1 (de) 2006-01-15

Family

ID=8159678

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01960178T ATE314465T1 (de) 2000-08-29 2001-07-17 Verfahren zum screening von hochaktiven proteasen und hemmstoffen

Country Status (7)

Country Link
US (1) US20040038375A1 (de)
EP (1) EP1315806B1 (de)
AT (1) ATE314465T1 (de)
AU (1) AU2001281734A1 (de)
CA (1) CA2419860A1 (de)
DE (1) DE60116337D1 (de)
WO (1) WO2002018588A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080090745A1 (en) * 2006-10-13 2008-04-17 Fox Bryan P Expression of Streptomyces subtilism inhibitor (SSI) proteins in Bacillus and Streptomyces sp.
WO2013054774A1 (ja) * 2011-10-12 2013-04-18 三洋化成工業株式会社 タンパク質性プロテアーゼインヒビター並びにこれを含有するタンパク質溶液及び洗剤組成物
JP6591998B2 (ja) * 2014-03-28 2019-10-16 ノボザイムス アクティーゼルスカブ 低pHでのタンパク質結晶の再可溶化
US12019066B2 (en) * 2016-05-16 2024-06-25 Biomadison, Inc. Assay with synaptobrevin based moiety
WO2017201079A1 (en) 2016-05-16 2017-11-23 Biomadison, Inc. Improved assay with synaptobrevin based moiety
US20210380667A1 (en) * 2018-10-10 2021-12-09 Novozymes A/S Chymotrypsin Inhibitor Variants And The Use Thereof
WO2023225459A2 (en) 2022-05-14 2023-11-23 Novozymes A/S Compositions and methods for preventing, treating, supressing and/or eliminating phytopathogenic infestations and infections
WO2026136410A1 (en) * 2024-12-17 2026-06-25 Danisco Us Inc. Intracellular co-expression of protease inhibitor in bacillus improves cell viability and enhances protease production

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993001305A1 (en) * 1991-07-09 1993-01-21 Robert Balint A method for the identification of protease inhibitors
US6159688A (en) * 1997-03-18 2000-12-12 Novo Nordisk A/S Methods of producing polynucleotide variants
JP2002534095A (ja) * 1999-01-08 2002-10-15 ブリストル−マイヤーズ スクイブ カンパニー プロテアーゼ活性を観察するために設計された原核細胞系

Also Published As

Publication number Publication date
CA2419860A1 (en) 2002-03-07
US20040038375A1 (en) 2004-02-26
AU2001281734A1 (en) 2002-03-13
EP1315806B1 (de) 2005-12-28
EP1315806A1 (de) 2003-06-04
DE60116337D1 (de) 2006-02-02
WO2002018588A1 (en) 2002-03-07

Similar Documents

Publication Publication Date Title
ATE279203T1 (de) Verwendung von substrat-subtraktionsbibliotheken zur unterscheidung von enzymspezifitäten
AU8843701A (en) Method and compositions for isolating metastatic cancer cells, and use in measuring metastatic potential of a cancer thereof
PL373399A1 (en) Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
SG166001A1 (en) Methods of generating and screening for proteases with altered specificity
EP2045321A3 (de) Serinproteasen mit veränderter Empfindlichkeit gegen aktivitätsmodulierende Substanzen
ATE458064T1 (de) Verfahren zur wirksamen rna-interferenz in säugerzellen
AU2003238717A1 (en) POLYPEPTIDES HAVING Alpha- H-Alpha-AMINO ACID AMIDE RACEMASE ACTIVITY AND NUCLEIC ACIDS ENCODING THE SAME
DE60116337D1 (de) Verfahren zum screening von hochaktiven proteasen und hemmstoffen
DE69902924D1 (de) Neue methoden zum auffinden von liganden- und ziel-biomolekülen
DK1440151T3 (da) Fröspecifik 7S-a-promotor til at udtrykke gener i planter
Albeck et al. Peptidyl Epoxides: Novel Selective Inactivators of Cysteine Proteases1
WO2003033673A3 (en) High-throughput transcriptome and functional validation analysis
WO2001016324A3 (en) Methods and compositions of a novel serine protease inhibitor
WO2004024898A3 (en) Nematode fatty acid desaturase-like sequences
DE50105206D1 (de) Verfahren zum selektieren von inhibitoren für enzyme
AU2003247599A1 (en) Methods of modulating cytokinin related processes in a plant using b3 domain proteins
ATE364078T1 (de) Verfahren zum nachweis von genen von sekretierten proteinen
DE60331414D1 (de) Aggrecanase-1- und -2-peptidsubstrate und verfahren
HK1043534A1 (zh) 蛋白酶抑制剂
WO2004026227A3 (en) A METHOD FOR GENERATION OF A RANDOM RNAi LIBRARY AND ITS APPLICATION IN CELL-BASED SCREENS
ATE461290T1 (de) Verfahren zur identifizierung von aktivestellen- proteasinaktivatoren
NO20025962D0 (no) Forbedrede kombinatoriske biblioteker ved rekombinasjon i gj¶r og analysemetode
DE502004011074D1 (de) Verfahren zur mikrobiologischen isomerisierung von alpha-hydroxycarbonsäuren
AU2003241604A1 (en) System and method for screening for protease inhibitors and proteases
ATE321877T1 (de) Fluoreszenz-verfahren zum nachweis von proteasen oder peptidasen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties